[1]
“Principle And Guidelines For Be Studies For Approval Of ANDA”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 12, no. 4, pp. 276–283, Oct. 2023, doi: 10.61096/ijrpp.v12.iss4.2023.276-283.